Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

Medication for the treatment of attention-deficit hyperactivity disorder (ADHD) is in
widespread use globally. There is considerable data suggesting that overall, the adverse …

The leading parent resource about attention-deficit/hyperactivity disorder (ADHD) and its
treatment has now been revised and updated with the latest information and resources …

ABSTRACT EEG biofeedback (neurofeedback) originated in the late 1960s as a method for
retraining brainwave patterns through operant conditioning. Since that time a sizable body of …

When first published in 1999, Your Drug May Be Your Problem was ahead of its time. The
only book to provide an uncensored description of the dangers involved in taking every kind …

Objective: This study examined the full spectrum of comorbid disorders in all statutory-health-
insured children aged 5 to 14 years with ADHD in 2017 by using nationwide claims data in …

Zusammenfassung Auf einen Blick Zusammenfassung Mit weit über 2 Milliarden DDD
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …

Children may be more susceptible to the effects of the environmental exposure and medical
treatments than adults; however, limited information is available about the differences in …

Filled with current, practical, and useful information for professionals and individuals, this
second edition of An ADHD Primer summarizes the literature concerning ADHD across the …

Have you prescribed a stimulant and been concerned about the risk of substance misuse or
diversion, the emergence of tics, or even sudden death? Have you been reluctant to …